The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 5, 2007, Pages 488.e1-488.e5

  Hendler, Israel ^a   Andrews, William W ^b   Carey, Christopher J ^c   Klebanoff, Mark A ^d   Noble, William D ^e   Sibai, Baha M ^f   Hillier, Sharon L ^g   Dudley, Donald ^h   Ernest, Joseph M ⁱ   Leveno, Kenneth J ^j   Wapner, Ronald ^k   Iams, Jay D ^l   Varner, Michael ^m   Moawad, Atef ⁿ   Miodovnik, Menachem ^o   O'Sullivan, Mary J ^p   Van Dorsten, Peter J ^q  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k THOMAS JEFFERSON UNIVERSITY   (United States)

^l THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^m UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF CHICAGO   (United States)

^o UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^p UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^q MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

antibiotic treatment; bacterial vaginosis; fetal fibronectin; preterm birth

Indexed keywords

ERYTHROMYCIN; FIBRONECTIN; LACTOSE; METRONIDAZOLE; PLACEBO;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; VAGINITIS;

EID: 35548936040     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.03.073     Document Type: Article

References (23)

1. Feinberg R.F., Kliman H.J., and Lockwood C.J. Is oncofetal fibronectin a trophoblast glue for human implantation?. Am J Pathol 138 (1991) 537-543
2. Goldenberg R.L., Mercer B.M., Meis P.J., Copper R.L., Das A., and McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth: NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 87 (1996) 643-648
3. Goldenberg R.L., Thom E., Moawad A.H., Johnson F., Roberts J., and Caritis S.N. The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection: NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 87 (1996) 656-660
4. Lockwood C.J., Senyei A.E., Dische M.R., et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 325 (1991) 669-674
5. Eschenbach D.A. History and review of bacterial vaginosis. Am J Obstet Gynecol 169 (1993) 441-445
6. Sobel J.D. Bacterial vaginosis. Annu Rev Med 51 (2000) 349-356
7. Hauth J.C., Goldenberg R.L., Andrews W.W., DuBard M.B., and Copper R.L. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 333 (1995) 1732-1736
8. Leitich H., Bodner-Adler B., Brunbauer M., Kaider A., Egarter C., and Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 189 (2003) 139-147
9. Andrews W.W., Hauth J.C., and Goldenberg R.L. Infection and preterm birth. Am J Perinatol 17 (2000) 357-365
10. Meis P.J., Goldenberg R.L., Mercer B., et al. The preterm prediction study: significance of vaginal infections: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 173 (1995) 1231-1235
11. Andrews W.W., Sibai B.M., Thom E.A., et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 101 (2003) 847-855
12. Carey J.C., Klebanoff M.A., Hauth J.C., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis: National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 342 (2000) 534-540
13. Klebanoff M.A., Carey J.C., Hauth J.C., et al., NICHD Maternal Fetal Medicine Units Network. Failure of metronidazole to prevent preterm birth among asymptomatic pregnant women with Trichomonas vaginalis. N Engl J Med 345 (2001) 487-493
14. Goldenberg R.L., Klebanoff M., Carey J.C., and Macpherson C. Metronidazole treatment of women with a positive fetal fibronectin test result. Am J Obstet Gynecol 185 (2001) 485-486
15. McGregor J.A., French J.I., Parker R., et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 173 (1995) 157-167
16. Klebanoff M.A., Hauth J.C., MacPherson C.A., et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 190 (2004) 363-370
17. Nugent R.P., Krohn M.A., and Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29 (1991) 297-301
18. Leitich H., Brunbauer M., Bodner-Adler B., Kaider A., Egarter C., and Husslein P. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 188 (2003) 752-758
19. Gratacos E., Figueras F., Barranco M., et al. Spontaneous recovery of bacterial vaginosis during pregnancy is not associated with an improved perinatal outcome. Acta Obstet Gynecol Scand 77 (1998) 37-40
20. Shennan A., Crawshaw S., Briley A., et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study. BJOG 113 (2006) 65-74
21. Rosenstein I.J., Morgan D.J., Lamont R.F., et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 8 (2000) 158-165
22. Eschenbach D.A. Bacterial vaginosis and anaerobes in obstetric-gynecologic infection. Clin Infect Dis 16 suppl (1993) S282-S287
23. Romero R., Chaiworapongsa T., Kuivaniemi H., and Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 190 (2004) 1509-1519